The DOI matches its Crossref record; 304 of the 304 references it cites were found in a registry or an index.
Neuropathology, biochemistry, and biophysics of α‐synuclein aggregation
Abstract
Aggregation of α‐synuclein, an abundant and conserved pre‐synaptic brain protein, is implicated as a critical factor in several neurodegenerative diseases. These diseases, known as synucleinopathies, include Parkinson’s disease, dementia with Lewy bodies (LBs), diffuse LB disease, the LB variant of Alzheimer’s disease, multiple system atrophy, and neurodegeneration with brain iron accumulation type I. Although the precise nature of in vivo α‐synuclein function remains elusive, considerable knowledge has been accumulated about its structural properties and conformational behavior. α‐Synuclein is a typical natively unfolded protein. It is characterized by the lack of rigid, well‐defined, 3‐D structure and possesses remarkable conformational plasticity. The structure of this protein depends dramatically on its environment and it accommodates a number of unrelated conformations. This paper provides an overview of the biochemistry, biophysics, and neuropathology of α‐synuclein aggregation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–304 of 304
Selkoe, D. J., Abraham, C. R., & Ihara, Y. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.19.6070 · Cited by 218
Rifampicin Inhibits α-Synuclein Fibrillation and Disaggregates Fibrils
Li, J., Zhu, M., Rajamani, S., Uversky, V. N., & Fink, A. L. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.08.025 · Cited by 218
Self-citationReview: Modulating Factors in Amyloid-β Fibril Formation
McLaurin, J., Yang, D.-S., Yip, C. M., & Fraser, P. E. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4289 · Cited by 218
Role of Protein−Water Interactions and Electrostatics in α-Synuclein Fibril Formation
Munishkina, L. A., Henriques, J., Uversky, V. N., & Fink, A. L. (2004) · Biochemistry · doi:10.1021/bi034938r · Cited by 215
Self-citationMagnesium Inhibits Spontaneous and Iron-induced Aggregation of α-Synuclein
Golts, N., Snyder, H., Frasier, M., Theisler, C., Choi, P., & Wolozin, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107866200 · Cited by 214
Rapid Anionic Micelle-mediated α-Synuclein Fibrillization in Vitro
Necula, M., Chirita, C. N., & Kuret, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308231200 · Cited by 211
Beyer, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0104-6 · Cited by 209
Trimethylamine‐ N ‐oxide‐induced folding of α‐synuclein
Uversky, V. N., Li, J., & Fink, A. L. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03121-0 · Cited by 208
Zhou, W., Hurlbert, M. S., Schaack, J., Prasad, K. N., & Freed, C. R. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02215-0 · Cited by 204
Krishnan, S., Chi, E. Y., Wood, S. J., Kendrick, B. S., Li, C., Garzon-Rodriguez, W., Wypych, J., Randolph, T. W., Narhi, L. O., Biere, A. L., et al. (2003) · Biochemistry · doi:10.1021/bi026528t · Cited by 202
Tubulin Seeds α-Synuclein Fibril Formation
Alim, M. A., Hossain, M. S., Arima, K., Takeda, K., Izumiyama, Y., Nakamura, M., Kaji, H., Shinoda, T., Hisanaga, S., & Uéda, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m102981200 · Cited by 200
Uversky, V. N., Li, J., Bower, K., & Fink, A. L. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00067-0 · Cited by 200
Self-citationThe role of α-synuclein in neurodegenerative diseases
Bennett, M. C. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.10.010 · Cited by 197
Lindersson, E., Lundvig, D., Petersen, C., Madsen, P., Nyengaard, J. R., Højrup, P., Moos, T., Otzen, D., Gai, W.-P., Blumbergs, P. C., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410409200 · Cited by 196
Daughdrill, G. W., Pielak, G. J., Uversky, V. N., Cortese, M. S., & Dunker, A. K. (2005) · Protein Folding Handbook · doi:10.1002/9783527619498.ch41 · Cited by 191
Self-citationSharon, R., Bar-Joseph, I., Mirick, G. E., Serhan, C. N., & Selkoe, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309127200 · Cited by 187
Uversky, V. N., Lee, H.-J., Li, J., Fink, A. L., & Lee, S.-J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100551200 · Cited by 186
Self-citationSolvent-induced collapse of α-synuclein and acid-denatured cytochrome c
Pielak, G. J., Morar, A. S., Olteanu, A., & Young, G. B. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/wshb-5d82 · Cited by 184
Effects of nitration on the structure and aggregation of α-synuclein
Uversky, V. N., Yamin, G., Munishkina, L. A., Karymov, M. A., Millett, I. S., Doniach, S., Lyubchenko, Y. L., & Fink, A. L. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.11.014 · Cited by 181
Self-citationMetal-Catalyzed Oxidation of α-Synuclein in the Presence of Copper(II) and Hydrogen Peroxide
Paik, S. R., Shin, H.-J., & Lee, J.-H. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1822 · Cited by 180
Identification of Novel Proteins Associated with Both α-Synuclein and DJ-1
Jin, J., Li, G. J., Davis, J., Zhu, D., Wang, Y., Pan, C., & Zhang, J. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600182-mcp200 · Cited by 179
Certain Metals Trigger Fibrillation of Methionine-oxidized α-Synuclein
Yamin, G., Glaser, C. B., Uversky, V. N., & Fink, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303302200 · Cited by 178
Self-citationCa2+ Binding to α-Synuclein Regulates Ligand Binding and Oligomerization
Nielsen, M. S., Vorum, H., Lindersson, E., & Jensen, P. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101181200 · Cited by 176
Macromolecular Crowding in the Escherichia coli Periplasm Maintains α-Synuclein Disorder
McNulty, B. C., Young, G. B., & Pielak, G. J. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.11.033 · Cited by 176
Aluminum-containing antacids as a cause of idiopathic Parkinson's disease
Altschuler, E. (1999) · Medical Hypotheses · doi:10.1054/mehy.1997.0701 · Cited by 173
Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for α-synuclein
Arawaka, S., Saito, Y., Murayama, S., & Mori, H. (1998) · Neurology · doi:10.1212/wnl.51.3.887 · Cited by 172
Goedert, M. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0466 · Cited by 172
Environmental factors and Parkinson's disease: A case‐control study in China
Tanner, C. M., Chen, B., Wang, W., Peng, M., Liu, Z., Liang, X., Kao, L. C., Gilley, D. W., Goetz, C. G., & Schoenberg, B. S. (1989) · Neurology · doi:10.1212/wnl.39.5.660 · Cited by 170
Membrane Binding and Self-Association of α-Synucleins
Narayanan, V., & Scarlata, S. (2001) · Biochemistry · doi:10.1021/bi002952n · Cited by 170
Sun, H., Gao, J., Ferrington, D. A., Biesiada, H., Williams, T. D., & Squier, T. C. (1998) · Biochemistry · doi:10.1021/bi981295k · Cited by 169
Methionine oxidation, α-synuclein and Parkinson's disease
Glaser, C. B., Yamin, G., Uversky, V. N., & Fink, A. L. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.10.008 · Cited by 168
Self-citationNitration inhibits fibrillation of human α‐synuclein in vitro by formation of soluble oligomers
Yamin, G., Uversky, V. N., & Fink, A. L. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00367-3 · Cited by 167
Self-citationLowe, R., Pountney, D. L., Jensen, P. H., Gai, W. P., & Voelcker, N. H. (2004) · Protein Science · doi:10.1110/ps.04879704 · Cited by 165
Tissue Transglutaminase Is Increased in Huntington's Disease Brain
(1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.02018.x · Cited by 164
Bodles, A. M., Guthrie, D. J. S., Greer, B., & Irvine, G. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00408.x · Cited by 163
Calcium, magnesium and aluminum concentrations in Parkinson's disease.
YASUI, M., Kihira, T., & Ota, K. (1992) · PubMed · Cited by 163
Natively Disordered Proteins: Functions and Predictions
Romero, P., Obradovic, Z., & Dunker, A. K. (2004) · Applied Bioinformatics · doi:10.2165/00822942-200403020-00005 · Cited by 163
Snaring the Function of α-Synuclein
Bonini, N. M., & Giasson, B. I. (2005) · Cell · doi:10.1016/j.cell.2005.10.017 · Cited by 162
Anti-HIV Activity of Medicinal Herbs: Usage and Potential Development
Wu, J. A., Attele, A. S., Zhang, L., & Yuan, C.-S. (2001) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x01000083 · Cited by 158
Li, J., Uversky, V. N., & Fink, A. L. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00066-9 · Cited by 158
Self-citationCrowther, R. A., Daniel, S. E., & Goedert, M. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01440-3 · Cited by 155
Occupational Metal Exposures and the Risk of Parkinson’s Disease
Gorell, J. M., Rybicki, B. A., Johnson, C. C., & Peterson, E. L. (1999) · Neuroepidemiology · doi:10.1159/000026225 · Cited by 150
Parkinson's Disease and Related α‐Synucleinopathies Are Brain Amyloidoses
Trojanowski, J. Q., & LEE, V. M. ‐. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07468.x · Cited by 150
Paik, S. R., Lee, J., Kim, D.-H., Chang, C., & Kim, J. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0207 · Cited by 149
Review: Amyloidogenesis—Unquestioned Answers and Unanswered Questions
Kisilevsky, R. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4222 · Cited by 148
Association between cardiac denervation and parkinsonism caused by α‐synuclein gene triplication
Singleton, A., Gwinn, K. A., Sharabi, Y., Li, S., Holmes, C. S., Dendi, R., Hardy, J., Singleton, A., Crawley, A., & Goldstein, D. S. (2004) · Brain · doi:10.1093/brain/awh081 · Cited by 147
Talpade, D. J., Greene, J. G., Higgins, D. S., & Greenamyre, J. T. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752611.x · Cited by 142
A case‐control study of Parkinson's disease in a horticultural region of British Columbia
Hertzman, C., Wiens, M., Snow, B. J., Kelly, S., & Calne, D. B. (1994) · Movement Disorders · doi:10.1002/mds.870090111 · Cited by 137
Gai, W. P., Power, J. H., Blumbergs, P. C., Culvenor, J. G., & Jensen, P. H. (1999) · PubMed · Cited by 136
Moskovitz, J., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., Jurský, F., Weissbach, H., & Brot, N. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3205 · Cited by 135
Epidemiology of Parkinsonʼs disease and akinetic syndromes
Tanner, C. M., & Aston, D. A. (2000) · Current Opinion in Neurology · doi:10.1097/00019052-200008000-00010 · Cited by 133
Polycation‐induced oligomerization and accelerated fibrillation of human α‐synuclein in vitro
Goers, J. W. F., Uversky, V. N., & Fink, A. L. (2003) · Protein Science · doi:10.1110/ps.0230903 · Cited by 132
Self-citationCombining prediction, computation and experiment for the characterization of protein disorder
Bracken, C., Iakoucheva, L. M., Romero, P. R., & Dunker, A. K. (2004) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2004.08.003 · Cited by 132
The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part I
Litvan, I., Halliday, G. M., Hallett, M., Goetz, C. G., Rocca, W. A., Duyckaerts, C. J., Ben‐Shlomo, Y., Dickson, D. W., Lang, A. E., Chesselet, M., et al. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3180415e42 · Cited by 130
Takahashi, M., Kanuka, H., Fujiwara, H., Koyama, A., Hasegawa, M., Miura, M., & Iwatsubo, T. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01258-2 · Cited by 129
Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?
Maguire‐Zeiss, K. A., Short, D. W., & Federoff, H. J. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.09.014 · Cited by 127
Golovko, M. Y., Færgeman, N. J., Cole, N. B., Castagnet, P. I., Nussbaum, R. L., & Murphy, E. J. (2005) · Biochemistry · doi:10.1021/bi0502137 · Cited by 125
Occupational Metal Exposures and the Risk of Parkinson’s Disease
Raterman, K. (2011) · Cited by 124
Fatty acid incorporation is decreased in astrocytes cultured from α‐synuclein gene‐ablated mice
Castagnet, P. I., Golovko, M. Y., Barceló‐Coblijn, G., Nussbaum, R. L., & Murphy, E. J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03247.x · Cited by 124
Nishie, M., Mori, F., Yoshimoto, M., Takahashi, H., & Wakabayashi, K. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00564.x · Cited by 123
Binding of α-Synuclein Affects the Lipid Packing in Bilayers of Small Vesicles
Kamp, F., & Beyer, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512292200 · Cited by 123
Gai, W. P., Power, J. H. T., Blumbergs, P. C., Culvenor, J. G., & Jensen, P. H. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.02093.x · Cited by 122
Ikezoe, T., Chen, S. S., Heber, D., Taguchi, H., & Koeffler, H. P. (2001) · The Prostate · doi:10.1002/pros.10024 · Cited by 120
Nishie, M., Mori, F., Fujiwara, H., Hasegawa, M., Yoshimoto, M., Iwatsubo, T., Takahashi, H., & Wakabayashi, K. (2004) · Acta Neuropathologica · doi:10.1007/s00401-003-0811-1 · Cited by 118
Forcing Nonamyloidogenic β-Synuclein To Fibrillate
Yamin, G., Munishkina, L. A., Karymov, M. A., Lyubchenko, Y. L., Uversky, V. N., & Fink, A. L. (2005) · Biochemistry · doi:10.1021/bi048778a · Cited by 115
Self-citationA Pure Parkinsonian Syndrome Following Acute Carbon Monoxide Intoxication
Klawans, H. L., Stein, R. W., Tanner, C. M., & Goetz, C. G. (1982) · Archives of Neurology · doi:10.1001/archneur.1982.00510170044012 · Cited by 114
Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease
Scherzer, C. R., Jensen, R. V., Gullans, S. R., & Feany, M. Β. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg265 · Cited by 113
TorsinA accumulation in Lewy bodies in sporadic Parkinson’s disease
Shashidharan, P., Good, P. F., Hsu, A., Perl, D. P., Brin, M. F., & Olanow, C. W. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02702-5 · Cited by 107
Immunohistochemical localization and distribution of torsinA in normal human and rat brain
Shashidharan, P., Kramer, B. C., Walker, R. H., Olanow, C. W., & Brin, M. F. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02232-5 · Cited by 105
α-Synuclein Association with Phosphatidylglycerol Probed by Lipid Spin Labels
Ramakrishnan, M., Jensen, P. H., & Marsh, D. (2003) · Biochemistry · doi:10.1021/bi035048e · Cited by 101
Book Review: Iron and Parkinson’s Disease
Wolozin, B. L., & Golts, N. (2002) · The Neuroscientist · doi:10.1177/107385840200800107 · Cited by 100
α-Synuclein Can Function as an Antioxidant Preventing Oxidation of Unsaturated Lipid in Vesicles
Zhu, M., Qin, Z., Hu, D., Munishkina, L. A., & Fink, A. L. (2006) · Biochemistry · doi:10.1021/bi052584t · Cited by 100
Transglutaminase Cross‐Linking of the τ Protein
Miller, M. L., & Johnson, G. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65041760.x · Cited by 99
Role of Individual Methionines in the Fibrillation of Methionine-Oxidized α-Synuclein
Hokenson, M. J., Uversky, V. N., Goers, J. W. F., Yamin, G., Munishkina, L. A., & Fink, A. L. (2004) · Biochemistry · doi:10.1021/bi049979h · Cited by 97
Self-citationAlpha-synuclein dysfunction in Lewy body diseases
Tofaris, G. K., & Spillantini, M. G. (2005) · Movement Disorders · doi:10.1002/mds.20538 · Cited by 97
Pathogenic effects of α-synuclein aggregation
Lundvig, D. M. S., Lindersson, E., & Jensen, P. H. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.09.001 · Cited by 94
El‐Agnaf, O. M. A., Bodles, A. M., Guthrie, D. J. S., Harriott, P., & Irvine, G. B. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2580157.x · Cited by 92
Bayer, T. A., Jäkälä, P., Hartmann, T., Havas, L., McLean, C., Culvenor, J. G., Li, Q.-X., Masters, C. L., Falkai, P., & Beyreuther, K. T. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00311-0 · Cited by 89
Pathophysiology of synuclein aggregation in Lewy body disease
Mukaetova‐Ladinska, E. B., & McKeith, I. G. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.09.014 · Cited by 87
Sensitization of Neuronal Cells to Oxidative Stress with Mutated Human α‐Synuclein
Ko, L., Mehta, N. D., Farrer, M. J., Easson, C., Hussey, J., Yen, S. H., Hardy, J., & Yen, S.-H. C. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752546.x · Cited by 86
Pathobiology of the Lewy body.
Je, G., Vm, L., Schmidt, M. L., Ph, T., Iwatsubo, T., & Trojanowski, J. Q. (1999) · PubMed · Cited by 86
Takeda, A., Hashimoto, M., Mallory, M., Sundsumo, M., Hansen, L., & Masliah, E. (2000) · Acta Neuropathologica · doi:10.1007/pl00007441 · Cited by 83
α‐Synuclein–synaptosomal membrane interactions
Jo, E., Darabie, A. A., Han, K. A., Tandon, A., Fraser, P. E., & McLaurin, J. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04250.x · Cited by 83
Genetics of Parkinson's disease
Morris, H. R. (2005) · Annals of Medicine · doi:10.1080/07853890510007269 · Cited by 80
Annular α‐synuclein species from purified multiple system atrophy inclusions
Pountney, D. L., Lowe, R. D., Quilty, M. C., Vickers, J. C., Voelcker, N. H., & Gai, W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02533.x · Cited by 77
Bodles, A. M., Guthrie, D. J. S., Harriott, P., Campbell, P., & Irvine, G. B. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01219.x · Cited by 77
Agrin binds α-synuclein and modulates α-synuclein fibrillation
Liu, I., Uversky, V. N., Munishkina, L. A., Fink, A. L., Halfter, W. M., & Cole, G. J. (2005) · Glycobiology · doi:10.1093/glycob/cwj014 · Cited by 72
Self-citationCalcium-Triggered Membrane Interaction of the α-Synuclein Acidic Tail
Tamamizu‐Kato, S., Kosaraju, M. G., Kato, H., Raussens, V., Ruysschaert, J., & Narayanaswami, V. (2006) · Biochemistry · doi:10.1021/bi060939i · Cited by 72
Gérard, M., Debyser, Z., Desender, L., Kahle, P. J., Baert, J. H., Baekelandt, V., & Engelborghs, Y. (2006) · The FASEB Journal · doi:10.1096/fj.05-5126fje · Cited by 66
Convergent Pathobiologic Model of Parkinson's Disease
Maguire‐Zeiss, K. A., & Federoff, H. J. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07473.x · Cited by 60
de Laureto, P. P., Tosatto, L., Frare, E., et al. (2006) · Biochemistry · doi:10.1021/bi052614s · Cited by 58
Ohlson, C., & Hogstedt, C. (1981) · Scandinavian Journal of Work Environment & Health · doi:10.5271/sjweh.2549 · Cited by 57
αB-Crystallin is a major component of glial cytoplasmic inclusions in multiple system atrophy
Pountney, D. L., Treweek, T. M., Chataway, T., Huang, Y. M., Chegini, F., Blumbergs, P. C., Raftery, M. J., & Gai, W. P. (2005) · Neurotoxicity Research · doi:10.1007/bf03033778 · Cited by 56
A Novel Mechanism of Interaction between α-Synuclein and Biological Membranes
Kim, Y. S., Laurine, E., Woods, W. S., & Lee, S. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.05.004 · Cited by 54
Madine, J., Doig, A. J., & Middleton, D. A. (2006) · Biochemistry · doi:10.1021/bi052151q · Cited by 51
alpha-Synuclein filaments bind the transcriptional regulator HMGB-1.
Lindersson, E., Højrup, P., Gai, W., Locker, D., Martin, D., & Jensen, P. H. (2004) · PubMed · Cited by 50
Distribution and immunohistochemical characterization of torsinA immunoreactivity in rat brain
Walker, R. H., Brin, M. F., Sandu, D., Gujjari, P., Hof, P. R., Olanow, C. W., & Shashidharan, P. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02302-2 · Cited by 47
Bismuto, E., Martelli, P. L., Maio, A. D., Mita, D. G., Irace, G., & Casadio, R. (2002) · Biopolymers · doi:10.1002/bip.10058 · Cited by 42
Clinical and pathological features in hydrocarbon‐induced Parkinsonism
Pezzoli, G., Strada, O., Silani, V., Zecchinelli, A., Perbellini, L., Javoy-Agid, F., Ghidoni, P., Motti, E., Masini, T., Scarlato, G., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410400616 · Cited by 40
Evaluation of risk of Parkinson's disease in a cohort of licensed pesticide users
Vanacore, N., Nappo, A., Gentile, M., Brustolin, A. L., Palange, S., Liberati, A. M., Rezze, S. D., Caldora, G., Gasparini, M., Benedetti, F. M. N., et al. (2002) · Neurological Sciences · doi:10.1007/s100720200098 · Cited by 35
The role of environmental agents in Parkinson's disease
Monte, D. A. D. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(01)00020-2 · Cited by 32
Molecular Mechanisms of Parkinson's Disease
Rezaee, Z., Marandi, M., Alaei, H., & Esfarjani, F. (2019) · The Neuroscience Journal of Shefaye Khatam · doi:10.29252/shefa.8.1.120 · Cited by 31
Bodner, R. A., Housman, D. E., & Kazantsev, A. G. (2006) · Cell Cycle · doi:10.4161/cc.5.14.2929 · Cited by 29
Hero versus antihero: The multiple roles of α-synuclein in neurodegeneration
Cookson, M. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.03.011 · Cited by 21
Cited by
Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria
Dickson, D. W., Braak, H., Duda, J. E., Duyckaerts, C., Gasser, T., Halliday, G. M., Hardy, J., Leverenz, J. B., Del Tredici, K., Wszolek, Z. K., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70238-8 · Cited by 972
Function and structure of inherently disordered proteins
Dunker, A. K., Silman, I., Uversky, V. N., & Sussman, J. L. (2008) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.10.002 · Cited by 963
Self-citationLuk, K. C., Song, C., O'Brien, P., Stieber, A., Branch, J. R., Brunden, K. R., Trojanowski, J. Q., & Lee, V. M.-Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908005106 · Cited by 938
Mitochondrial dysfunction and oxidative stress in Parkinson's disease
Subramaniam, S. R., & Chesselet, M.-F. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.04.004 · Cited by 913
Degradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies
Ciechanover, A., & Kwon, Y. T. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.117 · Cited by 898
Metadata
- Authors
- Uversky, V. N.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2007-07-10
- Volume
- 103
- Issue
- 1
- Pages
- 17-37
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2051098162
- Cited by
- 567
- References
- 304
- FWCI
- 25.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.